Jeannette Lechner‐Scott

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

Sudarshini Ramanathan, Shekeeb S. Mohammad, Esther Tantsis et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 561 citations · Full text

Medicine, Neurology, Neuroscience +16

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue

Ulrich Roelcke, Ludwig Kappos, Jeannette Lechner‐Scott et al. · Neurology · 1997 · 475 citations

Life Sciences, Neurology, Neuroscience +17

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 416 citations · Full text

Life Sciences, Neurology, Neuroscience +12

MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood

Mathew Cox, Murray J. Cairns, Kaushal Gandhi et al. · PLoS ONE · 2010 · 244 citations · Full text

Life Sciences, Immunology, Neurology +17